Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

PURPOSE: Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decrease these problems. This retrospective study aimed to find the appropriate number of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Springerplus
Huvudupphovsmän: Tsai, Yi-Jian, Lin, Jen-Kou, Chen, Wei-Shone, Jiang, Jeng-Kai, Teng, Hao-Wei, Yen, Chueh-Chuan, Lin, Tzu-chen, Yang, Shung-Haur
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer International Publishing 2016
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://ncbi.nlm.nih.gov/pubmed/27563513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2976-9
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk